• About us
    • About ImaBiotech
    • Our team
    • Quality Engagement
    • Careers
    • Contact Imabiotech
  • Innovative platforms
    • Spatial Multi-Omics and Drug Distribution
    • Molecular Imaging
    • Laser Microdissection
    • Multimaging™ Solutions
    • Spatially Resolved Gene Expression
    • High Multiplexing Proteins & Cell Markers
    • Testing Panels
  • Therapeutic areas
    • Oncology
    • Dermatology
    • Ophthalmology
    • Respiratory diseases
    • Central Nervous System
    • Metabolic Disorders
  • Services
    • Overview of Services
    • Biodistribution
    • Biomarkers Discovery
    • Formulation Screening
    • Digital Pathology
    • Drug Delivery
    • PK/PD-Pharmacology
    • Safety support
    • Translational Research
    • Clinical Drug Efficacy
  • Resources
    • Conferences and Webinars
    • Articles and research
    • Press releases & In the Press
    • Imabiotech news

Imabiotech news

  • imaging-mass-spectrometry

    The Multimaging Cloud platform

  • imaging-mass-spectrometry

    MassBio and ImaBiotech

  • imaging-mass-spectrometry

    Run for Life

  • imaging-mass-spectrometry

    Berkeley Lab’s OpenMSI Licensed to ImaBiotech

  • imaging-mass-spectrometry

    Cosm’Innov

« Previous 1 … 4 5 6

Search news




© ImaBiotech 2018-2019